706
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Outcomes associated with concordance of oral antidiabetic drug treatments to prescribing information in patients with type 2 diabetes mellitus and chronic kidney disease

, , , &
Pages 586-595 | Accepted 08 Feb 2013, Published online: 28 Feb 2013

References

  • Diabetes. WHO. Available at: http://www.who.int/mediacentre/factsheets/fs312/en/ [Last accessed April 19, 2012]
  • National Diabetes Fact Sheet: National estimates and general information on diabetes and prediabetes in the United States, 2011. Centers for Disease Control and Prevention. 2012. Available at: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf [Last accessed 11 April 2012]
  • Diabetes Statistics. American Diabetes Association. 2012. Available at http://www.diabetes.org/diabetes-basics/diabetes-statistics/ Last accessed 11 April 2012]
  • National Chronic Kidney Disease Fact Sheet 2010. Centers for Disease Control and Prevention. 2012. Available at http://www.cdc.gov/diabetes/pubs/factsheets/kidney.htm. [Last accessed 11 April 2012]
  • USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease in the United States Chapter 6. United States Renal Data System 2012. Available at http://www.usrds.org/atlas10.aspx. [Last accessed 11 April 2012]
  • Burke J, Kovacs B, Borton L, et al. Health care utilization and costs in type 2 diabetes mellitus and their association with renal impairment. Postgrad Med 2012;124:77-91
  • National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 2007;49:S12-180
  • Chen SY, Siu K, Kovacs B, et al. Clinical and economic outcomes associated with National Kidney Foundation guideline-concordant oral antidiabetic drug treatment among type 2 diabetes patients with chronic kidney disease. Curr Med Res Opin 2012;28:1-9
  • Bell JS, Airaksinen MS, Lyles A, et al. Concordance is not synonymous with compliance or adherence. Br J Clin Pharmacol 2007;64:710-11
  • Glynase PresTab (Micronized Glyburide Tablets) [PI] New York: Pharmacia & Upjohn Company, Division of Pfizer, Inc., 2010
  • Glucotrol (Glipizide) [PI] New York: Roerig Division of Pfizer Inc., 2010
  • Amaryl (Glimeperide) [PI] New Jersey: Sanofi-Aventis U.S. LLC., 2012
  • Precose (Acarbose) [PI] Wayne, New Jersey: Bayer Healthcare Pharmaceutical Inc., 2011
  • Glyset (Miglitol) [PI] New York: Pharmacia & Upjohn Company, Division of Pfizer, Inc., 2011
  • Glucophage (Metformin) [PI] Princeton, New Jersey: Bristol-Meyers Squibb Company, 2009
  • Prandin (Repaglinide) [PI] Princeton, New Jersey: Novo Nordisk Inc., 2011
  • Starlix (Nateglinide) [PI] East Hanover, New Jersey: Novartis Pharmaceutical Corp., 2012
  • Avandia (Rosiglitazone) [PI] Research Triangle Park, North Carolina: GlaxoSmithKline, 2011
  • Actos (Pioglitazone) [PI] Deerfield, Illinois: Takeda Pharmaceuticals America, Inc., 2012
  • Januvia (Sitagliptin) [PI] Whitehouse Station, New Jersey: Merck and Co, Inc. 2012
  • Onglyza (Saxagliptin) Princeton, New Jersey: Bristol-Myers Squibb Company, 2011
  • Self-Insured Group Health Plans. Self-Insurance Institute of America, Inc. Available at http://www.siia.org/i4a/pages/index.cfm?pageid=4546. [Last accessed 11 January 2013]
  • D'Hoore W, Bouchaert A, Tilquin C. Practical consideration on the use of the Charlson comorbidity index with administrative databases. J Clin Epidemiol 1996;49:1429-33
  • Schneeweiss S, Maclure M. Use of comorbidity scores for control of confounding in studies using administrative databases. Int J Epidemiol 2000;29:891-8
  • Ginde AA, Blanc PG, Lieberman RM, et al. Validation of ICD-9-CM coding algorithm for improved identification of hypoglycemia visits. BMC Endocr Disord 2008;8:4-10
  • Mihaylova B, Briggs A, O'Hagan A, et al. Review of statistical methods for analysing healthcare resources and costs. Health Econ 2011;20:897-916
  • Greene WH, ed. Econometric Analysis. Fifth edn. Upper Saddle River, New Jersey: Pearson Education, Inc., 2003
  • Managed Care. Medline Plus website. Available at: http://www.nlm.nih.gov/medlineplus/managedcare.html. Last accessed 21 January 2013
  • Menzin J, Langley-Hawthorne C, Friedman M, et al. Potential short-term economic benefits of improved glycemic control: a managed care perspective. Diabetes Care 2001;24:51-5
  • Standards of medical care in diabetes – 2011. Diabetes Care 2011;34(Suppl 1):S11-61

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.